Stimulation of Osteogenic Differentiation in Stromal Cells of Giant Cell Tumour of Bone by Zoledronic Acid |
Yang, Tao
(Department of Orthopaedics, Guangzhou Liu Hua Qiao Hospital)
Zheng, Xiao-Fei (Department of Orthopaedics, Guangzhou Liu Hua Qiao Hospital) Li, Mei (Department of Orthopaedics, Guangzhou Liu Hua Qiao Hospital) Lin, Xi (Southern Medical University) Yin, Qing-Shui (Department of Orthopaedics, Guangzhou Liu Hua Qiao Hospital) |
1 | Arpornchayanon O, Leerapun T (2008). Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature. J Med Assoc Thai, 91, 1609-12. |
2 | Boissier S, Ferreras M, Peyruchaud O, et al (2000). Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res, 60, 2949-54. |
3 | Boonekamp PM, van der Wee-Pals LJ, van Wijk-van Lennep MM, Thesing CW, Bijvoet OL (1986). Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner, 1, 27-39. |
4 | Chang SS, Suratwala SJ, Jung KM, et al (2004). Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis. Clin Orthop Relat Res, 426, 103-9. DOI |
5 | Gibbs CP, Lewis VO, Peabody T (2005). Beyond bone grafting: techniques in the surgical management of benign bone tumors. Instr Course Lect, 54, 497-503. |
6 | Cheng YY, Huang L, Lee KM, et al (2004). Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int, 75, 71-7. DOI |
7 | Cowan RW, Singh G (2013). Giant cell tumor of bone: a basic science perspective. Bone, 52, 238-46. DOI ScienceOn |
8 | Fu L, Tang T, Miao Y, et al (2008). Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation. Bone, 43, 40-7. DOI ScienceOn |
9 | Huang L, Teng XY, Cheng YY, Lee KM, Kumta SM (2004). Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone, 34, 393-401. DOI ScienceOn |
10 | Luckman SP, Hughes DE, Coxon FP, et al (1998). Nitrogencontaining bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res, 13, 581-9. DOI ScienceOn |
11 | Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP (2006). Giant cell tumor of bone. Am J Clin Oncol, 29, 96-9. DOI ScienceOn |
12 | Sung HW, Kuo DP, Shu WP, et al (1982). Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am, 64, 755-61. DOI |
13 | Nishisho T, Hanaoka N, Endo K, Takahashi M, Yasui N (2011). Locally administered zoledronic Acid therapy for giant cell tumor of bone. Orthopedics, 34, e312-5. |
14 | Reid IR, Brown JP, Burckhardt P, et al (2002). Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med, 346, 653-61. DOI ScienceOn |
15 | Turcotte RE (2006). Giant cell tumor of bone. Orthop Clin North Am, 37, 35-51. DOI ScienceOn |
16 | Szendroi M (2004). Giant-cell tumour of bone. J Bone Joint Surg Br, 86, 5-12. |
17 | Tse LF, Wong KC, Kumta SM, et al (2008). Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone, 42, 68-73. DOI ScienceOn |
18 | Wang CZ, Chen SM, Chen CH, et al (2010). The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration. Biomaterials, 31, 8674-83. DOI ScienceOn |
19 | Werner M (2006). Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop, 30, 484-9. DOI |
20 | Zheng MH, Robbins P, Xu J, et al (2001). The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol, 16, 297-307. |
21 | Zwolak P, Manivel JC, Jasinski P, et al (2010). Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines. J Bone Joint Surg Am, 92, 162-8. DOI ScienceOn |
22 | Balke M, Campanacci L, Gebert C, et al (2010). Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. BMC Cancer, 10, 462. DOI ScienceOn |
23 | Gille O, Oliveira BA, Guerin P, et al (2012). Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy. Spine (Phila Pa 1976), 37, E396-9. DOI ScienceOn |
![]() |